Nivolumab and ipilimumab in recurrent or refractory cancer of unknown primary: a phase II trialMaria Pouyiourou, Alwin Krämer, Bianca Kraft et al.|Nature Communications|2023Cited by 36
Spatial transcriptomics reveals a molecular tumor budding signature in head and neck cancerIordanis Ourailidis, Jan Budczies, Stefan Duensing et al.|Genome Medicine|2026Cited by 1
Additional file 1 of Spatial transcriptomics reveals a molecular tumor budding signature in head and neck cancerIordanis Ourailidis, Jan Budczies, Markus Ball et al.|Figshare|2026Cited by 0
Spatial transcriptomics reveals a molecular tumor budding signature in head and neck cancerIordanis Ourailidis, Jan Budczies, Markus Ball et al.|Figshare|2026Cited by 0
Additional file 1 of Spatial transcriptomics reveals a molecular tumor budding signature in head and neck cancerIordanis Ourailidis, Jan Budczies, Markus Ball et al.|Figshare|2026Cited by 0